Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Massively parallel in vivo Perturb-seq reveals cell type-specific transcriptional networks in cortical development

ABSTRACT: Massively parallel in vivo Perturb-seq reveals cell type-specific transcriptional networks in cortical development

PROVIDER: PRJNA1049003 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Massively parallel in vivo Perturb-seq reveals cell type-specific transcriptional networks in cortical development

Project description:Leveraging AAV's versatile tropism and labeling capacity, we expanded the scale of in vivo CRISPR screen with single-cell transcriptomic phenotyping across embryonic to adult brains and peripheral nervous systems. Through extensive tests of 86 AAV serotypes, combined with transposon systems, we substantially amplified labeling and accelerated in vivo gene delivery from weeks to days. Our proof-of-principle in utero screen identified the pleiotropic effects of Foxg1, highlighting its tight regulation of distinct networks essential for cell fate specification of Layer 6 corticothalamic neurons. Notably, our platform can label >6% of cerebral cells, surpassing the current state-of-the-art efficacy at <0.1% by lentivirus, to achieve analysis of over 30,000 cells in one experiment and enable massively parallel in vivo Perturb-seq. Compatible with various phenotypic measurements (single-cell or spatial multi-omics), it presents a flexible approach to interrogate gene function across cell types in vivo, translating gene variants to their causal function.

2023-12-05 | GSE249416 | GEO

Massively parallel phenotyping of coding variants in cancer with Perturb-seq

Project description:Massively parallel phenotyping of coding variants in cancer with Perturb-seq

| PRJNA679579 | ENA

Massively Parallel Characterization and Prediction of Disease-Associated Branch Site Variants that Perturb RNA Splicing

Project description:Massively Parallel Characterization and Prediction of Disease-Associated Branch Site Variants that Perturb RNA Splicing

| PRJNA745470 | ENA

Mapping of copy-number alterations with massively parallel sequencing

Project description:This SuperSeries is composed of the following subset Series: GSE12019: Fine-scale mapping of copy-number alterations with massively parallel sequencing GSE13372: High-resolution mapping of copy-number alterations with massively parallel sequencing Refer to individual Series

2008-11-13 | E-GEOD-13373 | biostudies-arrayexpress

Massively parallel <i>in vivo</i> Perturb-seq reveals cell type-specific transcriptional networks in cortical development.

Project description:Systematic analysis of gene function across diverse cell types in vivo is hindered by two challenges: obtaining sufficient cells from live tissues and accurately identifying each cell's perturbation in high-throughput single-cell assays. Leveraging AAV's versatile cell type tropism and high labeling capacity, we expanded the resolution and scale of in vivo CRISPR screens: allowing phenotypic analysis at single-cell resolution across a multitude of cell types in the embryonic brain, adult brain, and peripheral nervous system. We undertook extensive tests of 86 AAV serotypes, combined with a transposon system, to substantially amplify labeling and accelerate in vivo gene delivery from weeks to days. Using this platform, we performed an in utero genetic screen as proof-of-principle and identified pleiotropic regulatory networks of Foxg1 in cortical development, including Layer 6 corticothalamic neurons where it tightly controls distinct networks essential for cell fate specification. Notably, our platform can label >6% of cerebral cells, surpassing the current state-of-the-art efficacy at <0.1% (mediated by lentivirus), and achieve analysis of over 30,000 cells in one experiment, thus enabling massively parallel in vivo Perturb-seq. Compatible with various perturbation techniques (CRISPRa/i) and phenotypic measurements (single-cell or spatial multi-omics), our platform presents a flexible, modular approach to interrogate gene function across diverse cell types in vivo, connecting gene variants to their causal functions.

| S-EPMC10542124 | biostudies-literature

Massively parallel engineering of persistent CAR-Ts

Project description:Massively parallel engineering of persistent CAR-Ts

| PRJNA833968 | ENA

Massively parallel engineering of persistent CAR-Ts

Project description:Massively parallel engineering of persistent CAR-Ts

| PRJNA906963 | ENA

Massively Parallel Characterization and Prediction of Disease-Associated Branch Site Variants that Perturb RNA Splicing

Project description:It is estimated that 10-30% of disease-associated genetic variants affect splicing. Splicing variants may generate deleteriously altered gene product and are potential therapeutic targets. However, experimental diagnosis for splicing variants is time-consuming and reliable computational prediction tools have not been established, especially for the 3’ end of introns. The major challenge lies in the redundant and ill-defined branch site motif therein. Here, we carried out unbiased massively parallel splicing assays on 5,307 disease-associated variants overlapped with branch sites. We observed that 11.0% (455 out of 4,154 valid comparisons) of candidate variants showed a consistent pattern of altered splicing across four experimental replicates, among which 244 candidates (6.1%) presented more than two-fold changes in the use of noncanonical splice sites and these are named high-confidence (HC) significant candidates.

2022-05-10 | GSE179892 | GEO

Massively parallel engineering of persistent CAR-Ts [GEO_CLASH_MIPS]

Project description:Massively parallel engineering of persistent CAR-Ts [GEO_CLASH_MIPS]

| PRJNA906968 | ENA

Massively parallel engineering of persistent CAR-Ts [XDRNA]

Project description:Massively parallel engineering of persistent CAR-Ts [XDRNA]

| PRJNA855251 | ENA